Many pathologies are characterized by poor blood vessel growth and reduced nutrient delivery to the surrounding tissue, introducing a need for tissue engineered blood vessels. Our lab has developed a 3D co-culture method to grow interconnected networks of pericyte-invested capillaries, which can anastamose with host vasculature following implantation to restore blood flow to ischemic tissues. However, if the engineered vessels contain endothelial cells (ECs) that are misaligned or contain wide junctional gaps, they may function improperly and behave more like the pathologic vessels that nourish tumors. The purpose of this study was to test the resistance to permeability of these networks in vitro, grown with different stromal cell types, as...
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the po...
To engineer tissues with clinically relevant dimensions, one must overcome the challenge of rapidly ...
<p>Texas Red-conjugated dextran (70 kDa) is added to the bulk gel for 30 minutes and allowed to free...
Replicating in vitro the complex in vivo tissue microenvironment has the potential to transform our ...
A major translational challenge in the fields of therapeutic angiogenesis and tissue engineering is ...
The development of vessel-like structures in vitro to mimic as well as to realize the possibility of...
<div><p>Pericytes enveloping the endothelium play an important role in the physiology and pathology ...
\u3cp\u3eA promising approach to overcome hypoxic conditions in tissue engineered constructs is to u...
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the po...
Pre-clinical drug research of vascular diseases requires in vitro models of vasculature that are ame...
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the po...
Microfluidic organ-on-a-chip designs are used to mimic human tissues, including the vasculature. Her...
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the po...
The generation of functional microvascular networks is critical for the development of advanced in v...
To engineer tissues with clinically relevant dimensions, one must overcome the challenge of rapidly ...
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the po...
To engineer tissues with clinically relevant dimensions, one must overcome the challenge of rapidly ...
<p>Texas Red-conjugated dextran (70 kDa) is added to the bulk gel for 30 minutes and allowed to free...
Replicating in vitro the complex in vivo tissue microenvironment has the potential to transform our ...
A major translational challenge in the fields of therapeutic angiogenesis and tissue engineering is ...
The development of vessel-like structures in vitro to mimic as well as to realize the possibility of...
<div><p>Pericytes enveloping the endothelium play an important role in the physiology and pathology ...
\u3cp\u3eA promising approach to overcome hypoxic conditions in tissue engineered constructs is to u...
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the po...
Pre-clinical drug research of vascular diseases requires in vitro models of vasculature that are ame...
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the po...
Microfluidic organ-on-a-chip designs are used to mimic human tissues, including the vasculature. Her...
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the po...
The generation of functional microvascular networks is critical for the development of advanced in v...
To engineer tissues with clinically relevant dimensions, one must overcome the challenge of rapidly ...
A promising approach to overcome hypoxic conditions in tissue engineered constructs is to use the po...
To engineer tissues with clinically relevant dimensions, one must overcome the challenge of rapidly ...
<p>Texas Red-conjugated dextran (70 kDa) is added to the bulk gel for 30 minutes and allowed to free...